Any disruption in the balance of the human microbiome can severely alter its function, causing infections or other diseases. The vaginal microbiome plays an important
Microbiota plays a fundamental role in the overall development and defences of human beings. The majority of indigenous microbiota exists in a mutually beneficial relationship
It has been long understood that the vaginal microflora is crucial in maintaining a normal physiological environment for the host and its involvement is deemed
The role of microbiota in health and diseases is being highlighted by numerous studies since its discovery. Depending on the localized regions, microbiota can
The World Health Organization predicts that major depressive disorder (MDD) will become a leading cause of disability globally by 2030.1) Reducing the burden of this
Major depressive disorder (MDD) is a highly prevalent and disabling mental illness affecting more than 350 million people globally as theleading cause of disability worldwide (WHO, 2017).
Major depressive disorder (MDD) is a leading cause of disability worldwide [1]. Actions to reduce the impact of depression on patients, families and healthcare systems
Current prescribing practices for major depressive disorder (MDD) produce limited treatment success. Although pharmacogenomics may improve outcomes by identifying genetically inappropriate medications, studies to date
Geriatric depression, which affects approximately 5% of older adults (age ≥65 years) in the United States,1,2 places substantial burdens on function, quality of life, and
To perform a meta-analysis of prospective, two-arm studies examining the clinical utility of using the combinatorial pharmacogenomic test, GeneSight Psychotropic, to inform treatment decisions for
Antidepressants are recommended for use in the treatment of moderate-to-severe major depression [1], but many patients fail to benefit from these medications. Between 30 and
